a simple blood test which could definitively inform expectant mothers whether their child has genetic abnormalities is being developed by the applied imaging corporation of santa clara and the uks medical research council the only method of prenatal genetic screening in widespread use today is amniocentesis an invasive procedure involving the removal of some of the amniotic fluid surrounding the foetus recently it has become apparent that small numbers of the unborn childs cells enter the mothers bloodstream the test being developed extracts these cells for genetic analysis researchers believe it will prove a less expensive and risky alternative to the amniocentesis test applied imaging corporation us 408 562 0250 uk 091 516 0505